Obstructive sleep apnea: management considerations in psychiatric patients
Taryn Heck,1 Monica Zolezzi21Pharmacy Department, University of Alberta Hospital, Alberta Health Services, Edmonton, AB, Canada; 2Clinical Pharmacy and Practice, College of Pharmacy, Qatar University, Doha, QatarAbstract: Psychiatric disorders and obstructive sleep apnea (OSA) are often com...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/16c8298a9453461288501cc5b1be7a7c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:16c8298a9453461288501cc5b1be7a7c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:16c8298a9453461288501cc5b1be7a7c2021-12-02T00:55:49ZObstructive sleep apnea: management considerations in psychiatric patients1178-2021https://doaj.org/article/16c8298a9453461288501cc5b1be7a7c2015-10-01T00:00:00Zhttps://www.dovepress.com/obstructive-sleep-apnea-management-considerations-in-psychiatric-patie-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Taryn Heck,1 Monica Zolezzi21Pharmacy Department, University of Alberta Hospital, Alberta Health Services, Edmonton, AB, Canada; 2Clinical Pharmacy and Practice, College of Pharmacy, Qatar University, Doha, QatarAbstract: Psychiatric disorders and obstructive sleep apnea (OSA) are often comorbid. However, there is limited information on the impact of psychotropic medications on OSA symptoms, on how to manage psychiatric pharmacotherapy in patients presenting with OSA, or on the effectiveness and challenges of OSA treatments in patients with comorbid mental illness. As such, the objective of this article is to provide an overview of some epidemiological aspects of OSA and treatment considerations in the management of OSA in individuals with comorbid psychiatric disorders. Predefined keywords were used to search for relevant literature in electronic databases. Data show that OSA is particularly prevalent in patients with psychiatric disorders. The medical care that patients with these comorbidities require can be challenging, as some of the psychiatric medications used by these patients may exacerbate OSA symptoms. As such, continuous positive airway pressure continues to be the first-line treatment, even in patients with psychiatric comorbidity. However, more controlled studies are required, particularly to determine continuous positive airway pressure compliance in patients with mental illness, the impact of treating OSA on psychiatric symptoms, and the impact of the use of psychotropic medications on OSA symptoms.Keywords: obstructive sleep apnea, psychiatric disorders, comorbidity, psychotropic medicationsHeck TZolezzi MDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 2691-2698 (2015) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Heck T Zolezzi M Obstructive sleep apnea: management considerations in psychiatric patients |
description |
Taryn Heck,1 Monica Zolezzi21Pharmacy Department, University of Alberta Hospital, Alberta Health Services, Edmonton, AB, Canada; 2Clinical Pharmacy and Practice, College of Pharmacy, Qatar University, Doha, QatarAbstract: Psychiatric disorders and obstructive sleep apnea (OSA) are often comorbid. However, there is limited information on the impact of psychotropic medications on OSA symptoms, on how to manage psychiatric pharmacotherapy in patients presenting with OSA, or on the effectiveness and challenges of OSA treatments in patients with comorbid mental illness. As such, the objective of this article is to provide an overview of some epidemiological aspects of OSA and treatment considerations in the management of OSA in individuals with comorbid psychiatric disorders. Predefined keywords were used to search for relevant literature in electronic databases. Data show that OSA is particularly prevalent in patients with psychiatric disorders. The medical care that patients with these comorbidities require can be challenging, as some of the psychiatric medications used by these patients may exacerbate OSA symptoms. As such, continuous positive airway pressure continues to be the first-line treatment, even in patients with psychiatric comorbidity. However, more controlled studies are required, particularly to determine continuous positive airway pressure compliance in patients with mental illness, the impact of treating OSA on psychiatric symptoms, and the impact of the use of psychotropic medications on OSA symptoms.Keywords: obstructive sleep apnea, psychiatric disorders, comorbidity, psychotropic medications |
format |
article |
author |
Heck T Zolezzi M |
author_facet |
Heck T Zolezzi M |
author_sort |
Heck T |
title |
Obstructive sleep apnea: management considerations in psychiatric patients |
title_short |
Obstructive sleep apnea: management considerations in psychiatric patients |
title_full |
Obstructive sleep apnea: management considerations in psychiatric patients |
title_fullStr |
Obstructive sleep apnea: management considerations in psychiatric patients |
title_full_unstemmed |
Obstructive sleep apnea: management considerations in psychiatric patients |
title_sort |
obstructive sleep apnea: management considerations in psychiatric patients |
publisher |
Dove Medical Press |
publishDate |
2015 |
url |
https://doaj.org/article/16c8298a9453461288501cc5b1be7a7c |
work_keys_str_mv |
AT heckt obstructivesleepapneamanagementconsiderationsinpsychiatricpatients AT zolezzim obstructivesleepapneamanagementconsiderationsinpsychiatricpatients |
_version_ |
1718403365349621760 |